Andexanet-Alfa-Associated Heparin Resistance in the Context of Hemorrhagic Stroke.

Müther M, Schwindt W, Mesters RM, Minnerup J, Stracke P, Holling M, Wiendl H, Stummer W

Research article (journal) | Peer reviewed

Abstract

Although well known to hematologists, the phenomenon is underrecognized among stroke clinicians. However, patients with intracranial hemorrhage frequently undergo endovascular or surgical interventions that require periprocedural administration of heparin.

Details about the publication

JournalNeurocritical Care
Volume37
Issue2
Page range372-376
StatusPublished
Release year2022 (01/12/2022)
Language in which the publication is writtenEnglish
DOI10.1007/s12028-022-01573-5
KeywordsAnticoagulants; Factor Xa; Factor Xa Inhibitors; Hemorrhage; Hemorrhagic Stroke; Heparin; Humans; Intracranial Hemorrhages; Recombinant Proteins

Authors from the University of Münster

Minnerup, Jens
Department for Neurology
Wiendl, Heinz Siegfried
Department for Neurology